13250-97-0 Usage
Uses
Used in Pharmaceutical Industry:
4-Hydroxy-7-methyl-1,8-naphthyridine-3-carboxylic acid is used as a pharmaceutical compound for its potential anti-inflammatory, antibacterial, and antifungal properties. It is being studied and developed for the treatment of various diseases, leveraging its multifaceted therapeutic capabilities.
Used in Drug Development:
In the field of drug development, 4-Hydroxy-7-methyl-1,8-naphthyridine-3-carboxylic acid serves as a key component in the creation of new medications. Its unique chemical structure and properties allow it to be a promising candidate for the treatment of a range of conditions, from infections to inflammatory disorders.
Used in Research:
4-Hydroxy-7-methyl-1,8-naphthyridine-3-carboxylic acid is utilized in research settings to explore its potential applications and mechanisms of action. Scientists are investigating how 4-Hydroxy-7-methyl-1,8-naphthyridine-3-carboxylic acid interacts with biological systems and how it can be optimized for therapeutic use, contributing to the advancement of medical knowledge and innovation.
Check Digit Verification of cas no
The CAS Registry Mumber 13250-97-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,2,5 and 0 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 13250-97:
(7*1)+(6*3)+(5*2)+(4*5)+(3*0)+(2*9)+(1*7)=80
80 % 10 = 0
So 13250-97-0 is a valid CAS Registry Number.
InChI:InChI=1/C10H8N2O3/c1-5-2-3-6-8(13)7(10(14)15)4-11-9(6)12-5/h2-4H,1H3,(H,14,15)(H,11,12,13)
13250-97-0Relevant academic research and scientific papers
Potential Antimalarials. I. 1,8-Naphthyridines
Barlin, Gordon B.,Tan, Weng-Lai
, p. 1065 - 1073 (2007/10/02)
A number of 1,8-naphthyridines including 8-aza analogues of chloroquine and amodiaquine, and similar 1,8-naphthyridines with 2- and 7-methyl substituents have been prepared.These compounds showed minimal antimalarial activity in a preliminary in vivo screen against Plasmodium vinckei vinckei.
